Finance

Beta
Lists
000230:KRX
Ildong Holdings Co Ltd
₩7,220.00
+3.14%
(+220.00) 1D
Jun 12, 3:30:25 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000230...
Open
₩7,150
High
₩7,330
Low
₩7,080
Mkt. cap
83.32B
Avg. vol.
31.04K
Volume
0.00
Dividend
1.39%
Quarterly dividend
₩25
Ex-dividend date
Mar 30, 2026
P/E ratio
4.97
52-wk high
₩17,170
52-wk low
₩6,610
EPS
₩1,452
Shares outstanding
11.54M
No. of employees
72
Open
₩7,150
High
₩7,330
Low
₩7,080
Mkt. cap
83.32B
Avg. vol.
31.04K
Volume
0.00
Dividend
1.39%
Quarterly dividend
₩25
Ex-dividend date
Mar 30, 2026
P/E ratio
4.97
52-wk high
₩17,170
52-wk low
₩6,610
EPS
₩1,452
Shares outstanding
11.54M
No. of employees
72
News stories
From sources across the web
About Ildong Holdings Co Ltd
CEODae Chang Park
Employees72
FoundedMar 14, 1941
Headquarters-
SectorPharmaceutical industry
Websiteildong.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
142.63B
150.51B
153.83B
148.88B
Cost of goods sold
90.07B
90.37B
94.75B
89.03B
Cost of revenue
90.07B
90.37B
94.75B
89.03B
Research and development expenses
9.09B
9.31B
9.10B
9.15B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42.45B
41.03B
40.07B
39.21B
Operating expense
55.09B
53.87B
54.03B
50.75B
Total operating expenses
145.16B
144.24B
148.78B
139.78B
Operating income
-2.53B
6.27B
5.05B
9.10B
Other non operating income
3.48B
16.77B
2.54B
686.67M
EBT including unusual items
-10.60B
24.61B
21.14B
6.47B
EBT excluding unusual items
-6.08B
24.63B
22.86B
5.51B
Income tax expense
-820.93M
9.96B
1.40B
698.69M
Effective tax rate
7.74%
40.49%
6.61%
10.79%
Other operating expenses
731.40M
574.48M
305.12M
298.90M
Net income
-5.20B
993.16M
19.26B
1.42B
Net profit margin
-3.64%
0.66%
12.52%
0.96%
Earnings per share
-
-
-
-
Interest and investment income
154.93M
159.54M
121.96M
144.10M
Interest expense
-6.49B
-5.67B
-4.13B
-2.27B
Net interest expenses
-6.33B
-5.51B
-4.01B
-2.12B
Depreciation and amortization charges
2.41B
2.53B
2.45B
2.37B
EBITDA
5.03B
12.58B
12.81B
16.08B
Gain or loss from assets sale
1.97B
-9.44B
-20.85B
10.12M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer